RASGRP3 and leukemia: We found that SCL was enriched in the promoter region of overexpressed genes by combination treatment, such as RASGRP3, PDGFB, and THBS1. Increased expression of SCL is associated with leukemia and poor prognosis of T-cell acute lymphoblastic leukemia67.